LFMD

LifeMD Inc. Common Stock (LFMD)

Stock · NASDAQ · Health Care

$2.35as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

LifeMD Announces Preferred Dividend and AT&T Partnership. LifeMD declared a quarterly dividend on its Series A cumulative perpetual preferred stock. The company also announced a partnership with AT&T that will provide free memberships, with the potential to convert some users into paying patients. These developments come as the common stock trades near its recent support level and the firm carries a high trailing P/E.

Active signals

High Beta51.9%
200 SMA Touch0.0%
Resistance level
$4.22
Industry
Medical/Nursing Services

What LFMD's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike40-0.2%48%
Bollinger Band Breakout28+0.2%50%
Bollinger Band Breakdown17-3.8%47%
200-Day Moving Average TouchActive now9-9.9%22%
Any 20-session window (baseline)-0.8%48%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About LFMD

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss…

Sector
Health Care
Industry
Medical/Nursing Services
Employees
347

Fundamentals

1-day range
$2.34$2.5
Market cap
$164.43M
P/E (trailing)
589.89
P/E (forward)
6.47
EPS (trailing)
$0.01
Dividend yield
—
Beta
2.10
Avg. volume
857.4K
Dividend pay date
October 14, 2020
52-week range
$2.36$6.53
Next earnings: November 9, 2026 · EPS estimate $0.11confirmed

How LifeMD Inc. Common Stock Makes Money

Where the revenue actually goes — FY2024 annual results

market-wall.comTotalRevenue$212.45MSG&A$175.68M (83%)Cost of Revenue$24.07M (11%)Other$12.30M (6%)Tax$402.0K (0%)LFMD

Source: 10-K filed Mar 11, 2025 · via SEC EDGAR / Finnhub

Gross Profit$188.39M(89%)
Operating Income-$16.14M(-8%)

Forecasts

8 analyst ratings

Buy 93%
Hold 7%
Sell 0%
1-year price forecast
High
$15
+538.3%
Median
$7.5
+219.1%
Low
$5
+112.8%

LifeMD Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • LFMD
    LifeMD Inc. Common Stock
    $2.34
    ▼ 4.88%
    Market cap $164.43MP/E 589.89
    $2.36$6.53
  • NAKA
    Nakamoto Inc. Common Stock
    $7.13
    ▼ 11.87%
    Market cap $86.14MP/E —
    $3.33$42
  • PIII
    P3 Health Partners Inc. Class A Common Stock
    $4.14
    ▲ 0.00%
    Market cap $78.90MP/E —
    $1.52$16.89
  • ALPS
    ALPS Group Inc Ordinary Share
    $0.34
    ▲ 0.29%
    Market cap $69.06MP/E —
    $0.2293$12.01
  • DCGO
    DocGo Inc. Common Stock
    $0.272
    ▼ 3.55%
    Market cap $61.74MP/E —
    $0.2711$1.65
  • EUDA
    EUDA Health Holdings Limited Ordinary Shares
    $15.4
    ▼ 0.58%
    Market cap $48.78MP/E —
    $5.26$86
  • SBC
    SBC Medical Group Holdings Incorporated Common Stock
    $5.16
    ▼ 2.64%
    Market cap $305.46MP/E 11.12
    $2.78$5.61

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
687.5K
Disposed
0

Institutional Ownership

March 31, 2026

Total shares held
17.75M
Total value held
$63.76M
Institutional holders
99
Top holders this quarter
  • Unknown2.81M
  • Unknown1.66M
  • Unknown1.20M
  • Unknown1.12M
  • Unknown1.08M
  • Unknown1.02M
  • Unknown1.02M
  • Unknown895.4K
  • Unknown871.6K
  • Unknown579.5K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.